133 related articles for article (PubMed ID: 38704945)
1. Recent advances of honokiol：pharmacological activities, manmade derivatives and structure-activity relationship.
Li X; Yuan Z; Wang Y; Wang W; Shi J
Eur J Med Chem; 2024 Jun; 272():116471. PubMed ID: 38704945
[TBL] [Abstract][Full Text] [Related]
2. Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review.
Pan C; Li Q; Xiong S; Yang Y; Yang Y; Huang C; Wang ZP
Chem Biodivers; 2024 Jun; 21(6):e202302032. PubMed ID: 38308434
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents.
Kim YS; Lee JY; Park J; Hwang W; Lee J; Park D
Arch Pharm Res; 2010 Jan; 33(1):61-5. PubMed ID: 20191344
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
Jada S; Doma MR; Singh PP; Kumar S; Malik F; Sharma A; Khan IA; Qazi GN; Kumar HM
Eur J Med Chem; 2012 May; 51():35-41. PubMed ID: 22424614
[TBL] [Abstract][Full Text] [Related]
5. Honokiol and magnolol: A review of structure-activity relationships of their derivatives.
Dai SY; Qin WX; Yu S; Li C; Yang YH; Pei YH
Phytochemistry; 2024 Jul; 223():114132. PubMed ID: 38714288
[TBL] [Abstract][Full Text] [Related]
6. Semisynthesis and biological evaluation of novel honokiol thioethers against colon cancer cells HCT116 via inhibiting the transcription and expression of YAP protein.
Yang R; Fu X; Fan J; Wang T; Song J; Xu T; Guo Y; Zhang SY
Bioorg Med Chem; 2024 Jun; 107():117762. PubMed ID: 38759254
[TBL] [Abstract][Full Text] [Related]
7. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
8. Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives.
Yang C; Zhi X; Xu H
Mini Rev Med Chem; 2016; 16(5):404-26. PubMed ID: 26586125
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.
Yang J; Shang J; Yang L; Wei D; Wang X; Deng Q; Zhong Z; Ye Y; Zhou M
Int J Nanomedicine; 2023; 18():6639-6665. PubMed ID: 38026538
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.
Ren C; Wang J; Tan Y; Guo M; Guo J; Liu Y; Wu X; Feng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302335
[TBL] [Abstract][Full Text] [Related]
12. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
13. Research Progress on the Structural Modification of Magnolol and Honokiol and the Biological Activities of Their Derivatives.
Ming-Xin Guo MM; Wu X; Feng YF; Hu ZQ
Chem Biodivers; 2023 Aug; 20(8):e202300754. PubMed ID: 37401658
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
Amblard F; Govindarajan B; Lefkove B; Rapp KL; Detorio M; Arbiser JL; Schinazi RF
Bioorg Med Chem Lett; 2007 Aug; 17(16):4428-31. PubMed ID: 17587572
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy.
Xu T; Tian W; Zhang Q; Liu J; Liu Z; Jin J; Guo Y; Bai LP
Bioorg Chem; 2021 Oct; 115():105257. PubMed ID: 34426156
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic neolignans: an SAR study.
Kong ZL; Tzeng SC; Liu YC
Bioorg Med Chem Lett; 2005 Jan; 15(1):163-6. PubMed ID: 15582432
[TBL] [Abstract][Full Text] [Related]
17. A Review on the Mechanism and Structure-activity Relationship of Resveratrol Heteroaryl Analogues.
Xiang Y; Xu Y; Li J; Jiang J; Wang Y; Li X; Ai W; Mi P; Yang Z; Zheng Z
Comb Chem High Throughput Screen; 2024; 27(7):947-958. PubMed ID: 37448369
[TBL] [Abstract][Full Text] [Related]
18. Honokiol Reduces Fungal Load, Toll-Like Receptor-2, and Inflammatory Cytokines in Aspergillus fumigatus Keratitis.
Zhan L; Peng X; Lin J; Zhang Y; Gao H; Zhu Y; Huan Y; Zhao G
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):48. PubMed ID: 32347916
[TBL] [Abstract][Full Text] [Related]
19. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Hideshima H; Shiraishi N; Yasui H; Roccaro AM; Richardson P; Podar K; Le Gouill S; Chauhan D; Tamura K; Arbiser J; Anderson KC
Blood; 2005 Sep; 106(5):1794-800. PubMed ID: 15870175
[TBL] [Abstract][Full Text] [Related]
20. Honokiol downregulates Kruppel-like factor 4 expression, attenuates inflammation, and reduces histopathology after spinal cord injury in rats.
Liu J; Zhang C; Liu Z; Zhang J; Xiang Z; Sun T
Spine (Phila Pa 1976); 2015 Mar; 40(6):363-8. PubMed ID: 25774462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
